IFNA1 and hepatocellular carcinoma: In a meta-analysis of 531 patients with HBV-HCC, IFN therapy seemed to reduce the risk of recurrence in HBV-related HCC following resection surgery, but the effect was not statistically significant (HR 0.87, 95% CI 0.70–1.09) [45].